Pulmonary embolism: Difference between revisions
mNo edit summary |
No edit summary |
||
Line 50: | Line 50: | ||
*'''[[Pulmonary embolism surgery|Surgery]]:''' | *'''[[Pulmonary embolism surgery|Surgery]]:''' | ||
:* | :*[[Pulmonary thrombectomy|Catheter-Based Interventions]] | [[Pulmonary thrombectomy|Surgical Embolectomy]] | [[Inferior vena cava filter|Inferior Vena Cava Filters]] | [[Thromboreductive Strategies]] | [[Pulmonary embolism angioplasty|Percutaneous Transluminal Venous Angioplasty and Stent Placement]] | [[Pulmonary thromboendarterectomy|Pulmonary Endarterectomy]] | ||
==Guidelines== | ==Guidelines== | ||
===ACC/AHA Guidelines=== | ===ACC/AHA Guidelines=== | ||
[[Pulmonary embolism recommendations for initial anticoagulation for acute PE| Guidelines for Initial Anticoagulation for Acute PE]] | [[ACC/AHA guidelines surgical embolectomy|Surgical embolectomy]] | [[Pulmonary embolism guidelines inferior vena cava filter#ACC/AHA Guidelines- Recommendations on IVC Filters in the Setting of Acute PE (DO NOT EDIT)|Inferior vena cava filters]] | [[Pulmonary embolism management recommendations for Iliofemoral Deep Vein Thrombosis|Iliofemoral DVT management guidelines]] | [[Compression therapy for DVT]] | [[Pulmonary embolism thromboreductive strategies#ACC/AHA Guidelines-Recommendations for Endovascular Thrombolysis and Surgical Venous Thrombectomy (DO NOT EDIT)|Thromboreductive Strategies]] | [[Pulmonary embolism angioplasty#ACC/AHA Guidelines- Recommendations for Percutaneous Transluminal Venous Angioplasty and Stenting (DO NOT EDIT)|Percutaneous Transluminal Venous Angioplasty and Stent Placement]] | |||
===ESC Guidelines=== | ===ESC Guidelines=== | ||
* | *[[Pulmonary embolism natural history#ESC Guidelines for Prognostic assessment (DO NOT EDIT)|Prognostic assessment]] | ||
*'''Diagnosis: | *'''Diagnosis:''' [[Pulmonary embolism guidelines diagnosis#ESC Guidelines for Suspected high-risk PE (DO NOT EDIT)|Suspected high-risk PE]] | [[Pulmonary embolism guidelines diagnosis#ESC Guidelines for Suspected non-high-risk PE (DO NOT EDIT)|Suspected non-high-risk PE]] | [[Pulmonary embolism guidelines diagnosis#Low clinical probability|Low clinical probability]] | [[Pulmonary embolism guidelines diagnosis#Intermediate clinical probability|Intermediate clinical probability]] | [[Pulmonary embolism guidelines diagnosis#High clinical probability)|High clinical probability )]] | ||
*'''Treatment: | *'''Treatment:''' [[Pulmonary embolism medical therapy#ESC Guidelines treatment High-risk pulmonary embolism (DO NOT EDIT)|High-risk pulmonary embolism]] | [[Pulmonary embolism medical therapy#ESC Guidelines treatment Non-high-risk pulmonary embolism (DO NOT EDIT)|Non-high-risk pulmonary embolism]] | [[Pulmonary embolism medical therapy#ESC Guidelines Recommendations Long-term treatment (DO NOT EDIT)|Long-term treatment]] | [[Pulmonary embolism guidelines inferior vena cava filter#ESC Guidelines - Recommendations for Use of IVC Filters (DO NOT EDIT)|Inferior vena cava filters]] | [[Pulmonary embolism treatment thrombolysis#ACC/AHA Guidelines- Recommendations for Fibrinolysis for Acute PE (DO NOT EDIT)|Thrombolysis]] | ||
==Discharge Care== | ==Discharge Care== |
Revision as of 16:54, 26 April 2012
For patient information click here
Pulmonary embolism | |
ICD-10 | I26 |
---|---|
ICD-9 | 415.1 |
DiseasesDB | 10956 |
MedlinePlus | 000132 |
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism On the Web |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification Scheme
I: Acute pulmonary embolism | Chronic pulmonary embolism
II: Massive pulmonary embolism | Submassive pulmonary embolism | Low-risk pulmonary embolism
III: Non-thrombotic pulmonary embolism
Pathophysiology
Epidemiology and Demographics
Risk factors
Natural History, Complications & Prognosis
Differential Diagnosis
Pretest probability of PE
Diagnosis
Diagnosis Algorithm | CT equipped Hospitals | CT Non-equipped Hospitals | Low risk outpatient population | History & Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | CT | Ventilation/Perfusion scan | Echocardiography or Ultrasound | Chest x ray | MRI | Low Probability Diagnostic Tests
Treatment
- Anticoagulation: Heparin | Low molecular weight heparin | Factor Xa inhibitor | Warfarin
- Fibrinolytic: Thrombolysis
Guidelines
ACC/AHA Guidelines
Guidelines for Initial Anticoagulation for Acute PE | Surgical embolectomy | Inferior vena cava filters | Iliofemoral DVT management guidelines | Compression therapy for DVT | Thromboreductive Strategies | Percutaneous Transluminal Venous Angioplasty and Stent Placement
ESC Guidelines
- Diagnosis: Suspected high-risk PE | Suspected non-high-risk PE | Low clinical probability | Intermediate clinical probability | High clinical probability )
- Treatment: High-risk pulmonary embolism | Non-high-risk pulmonary embolism | Long-term treatment | Inferior vena cava filters | Thrombolysis
Discharge Care
Discharge Care | Follow-Up/Recurrence | Support group